These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24427321)

  • 1. Proteomic analysis identifies proteins associated with curcumin-enhancing efficacy of irinotecan-induced apoptosis of colorectal cancer LOVO cell.
    Zhu DJ; Chen XW; Wang JZ; Ju YL; Ou Yang MZ; Zhang WJ
    Int J Clin Exp Pathol; 2014; 7(1):1-15. PubMed ID: 24427321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway.
    Huang YF; Zhu DJ; Chen XW; Chen QK; Luo ZT; Liu CC; Wang GX; Zhang WJ; Liao NZ
    Oncotarget; 2017 Jun; 8(25):40264-40275. PubMed ID: 28402965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening and identifying differentially expressed proteins in LST-R1 cells].
    Tong HS; Lai XR; Zhang YL; Jiang B; Su L
    Ai Zheng; 2008 Dec; 27(12):1277-82. PubMed ID: 19079993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on functions and mechanism of curcumin in inducing colorectal carcinoma cells LoVo apoptosis].
    Guo LD; Jiao ZX; Song Y; Teng WH; Liu Z; Liu JZ
    Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2191-6. PubMed ID: 24079252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perifosine sensitizes curcumin-induced anti-colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro.
    Chen MB; Wu XY; Tao GQ; Liu CY; Chen J; Wang LQ; Lu PH
    Int J Cancer; 2012 Dec; 131(11):2487-98. PubMed ID: 22438101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proteomic research of biomarker of colorectal cancer metastasis].
    Zhang P; Huang L; Ma YL; Peng JY; Shen TY; Chen HQ; Zhou YK; Chu ZX; Zhang M; Qin HL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):618-22. PubMed ID: 19921578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial-mesenchymal transition.
    Zhang C; Xu Y; Wang H; Li G; Yan H; Fei Z; Xu Y; Li W
    Anticancer Drugs; 2018 Apr; 29(4):334-340. PubMed ID: 29420338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic analysis of irinotecan-sensitive colorectal carcinoma cell line and its chemoresistant counterpart.
    Gong FM; Peng XC; Tan BX; Ge J; Chen X; Chen Y; Xu F; Bi F; Hou JM; Liu JY
    Anticancer Drugs; 2011 Jul; 22(6):500-6. PubMed ID: 21637159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoA regulates resistance to irinotecan by regulating membrane transporter and apoptosis signaling in colorectal cancer.
    Ruihua H; Mengyi Z; Chong Z; Meng Q; Xin M; Qiulin T; Feng B; Ming L
    Oncotarget; 2016 Dec; 7(52):87136-87146. PubMed ID: 27888624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of cell lines to identify the irinotecan resistance proteins.
    Peng XC; Gong FM; Wei M; Chen X; Chen Y; Cheng K; Gao F; Xu F; Bi F; Liu JY
    J Biosci; 2010 Dec; 35(4):557-64. PubMed ID: 21289438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.
    Signore M; Buccarelli M; Pilozzi E; De Luca G; Cappellari M; Fanciulli M; Goeman F; Melucci E; Biffoni M; Ricci-Vitiani L
    Oncotarget; 2016 Jul; 7(28):44113-44128. PubMed ID: 27286453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Sestrin3 Involved in the In vitro Resistance of Colorectal Cancer Cells to Irinotecan.
    Choi SH; Hong HK; Cho YB; Lee WY; Yoo HY
    PLoS One; 2015; 10(5):e0126830. PubMed ID: 25973791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
    Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
    World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells.
    Koizumi F; Kanzawa F; Ueda Y; Koh Y; Tsukiyama S; Taguchi F; Tamura T; Saijo N; Nishio K
    Int J Cancer; 2004 Jan; 108(3):464-72. PubMed ID: 14648715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.
    Wang Y; Yang L; Zhang J; Zhou M; Shen L; Deng W; Liang L; Hu R; Yang W; Yao Y; Zhang H; Zhang Z
    Int J Oncol; 2018 Oct; 53(4):1667-1680. PubMed ID: 30085332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
    Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A
    Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway.
    Guo LD; Chen XJ; Hu YH; Yu ZJ; Wang D; Liu JZ
    Phytother Res; 2013 Mar; 27(3):422-30. PubMed ID: 22628241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the cytotoxicity of irinotecan in two human colorectal tumor cell lines.
    Pavillard V; Agostini C; Richard S; Charasson V; Montaudon D; Robert J
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):329-35. PubMed ID: 11914913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
    Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
    Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.